000 01425 a2200409 4500
005 20250517212304.0
264 0 _c20190218
008 201902s 0 0 eng d
022 _a1534-6080
024 7 _a10.1097/TP.0000000000002247
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVille, Simon
245 0 0 _aBelatacept and Autoimmune Adverse Events.
_h[electronic resource]
260 _bTransplantation
_c07 2018
300 _ae355-e356 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAbatacept
_xadverse effects
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAdult
650 0 4 _aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
_xcomplications
650 0 4 _aAutoimmunity
_xdrug effects
650 0 4 _aBiopsy
650 0 4 _aCalcitriol
_xanalogs & derivatives
650 0 4 _aGraft Rejection
_xpathology
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aKidney Failure, Chronic
_xetiology
650 0 4 _aKidney Transplantation
_xadverse effects
650 0 4 _aMale
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aRituximab
_xtherapeutic use
650 0 4 _aSkin
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aCantarovich, Diego
773 0 _tTransplantation
_gvol. 102
_gno. 7
_gp. e355-e356
856 4 0 _uhttps://doi.org/10.1097/TP.0000000000002247
_zAvailable from publisher's website
999 _c28304075
_d28304075